Ian is the editor and a director of Proactive Investors. He oversees all editorial output and is also heavily involved with business development. He moved to Proactive from the Daily Mail, where he was City News Editor and Investment Editor and brings with him a wealth of experience in business and finance. At the Mail he directed the coverage of some of the biggest stories ever to emerge from the City as the credit crunch and banking crisis felled some of the nation's best known financial institutions. In his 20 years as a business reporter and editor Ian has worked for Dow Jones, writing stories for the international news wire and the Wall Street Journal. He also led the London company coverage for AFX News, now part of Reuters.
Higher volumes from key customers and strong demand for pericardium tissue were behind the surge.
The deal validates the licensing model, says chief executive, Dr Alastair Smith
The EASE study will assess the progress of 164 patients across 30 sites in 15 countries with Sydney, Australia, the first to begin work
The company said it is preparing to meet with US regulators on plans for a phase III trial of its treatment for victims of stroke, while it wants to expand its ophthalmology study
He has over 35 years’ experience in the life sciences arena
Dr Gregory Brown and John Poulos bring with them a breadth and depth of industry experience
It has found a specialist outsourced sales group that will target the 64 hospitals on the island.
The transformation of the business was reflected by top line growth of 510%
Two companies, three wells
Drilling down into the world of E&P as we keep tabs of on the gushers and dusters
A look at some early analyst views in the City
The bookmakers have been put under the microscope, while Shell has been downgraded.